Phaarmasia informs about disclosure

11 Nov 2022 Evaluate
Phaarmasia has informed that the Company is in receipt of the initial public announcement dated 11th November, 2022 made by Saffron Capital Advisors, Manager to the Offer, on behalf of Maneesh Pharmaceuticals, representing the Promoter Group of Phaarmasia (Company) in accordance with Regulation 8 of the SEBI (Delisting of Equity Shares) Regulations 2021, as amended, expressing the intention to voluntary delist the equity shares of the Company (Initial Public Announcement or IPA.

The above information is a part of company’s filings submitted to BSE.

Phaarmasia Share Price

29.10 -0.01 (-0.03%)
28-Mar-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1620.50
Dr. Reddys Lab 6171.85
Cipla 1494.65
Zydus Lifesciences 1013.75
Lupin 1617.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.